First-line therapy in Helicobacter pylori eradication therapy: experience of a surgical clinic

Creative Commons License

Özbalcı G. S., YÜRÜKER S. S., Tarım İ. A., Cinar H., Polat A. K., Ozbalci A. B., ...Daha Fazla

TURKISH JOURNAL OF SURGERY, cilt.30, sa.3, ss.133-137, 2014 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 30 Sayı: 3
  • Basım Tarihi: 2014
  • Doi Numarası: 10.5152/ucd.2014.2678
  • Dergi Adı: TURKISH JOURNAL OF SURGERY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.133-137
  • Anahtar Kelimeler: Helicobacter pylori, eradication, triple therapy, quadruple therapy
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

Objective: Helicobacter pylori (HP) is the world's most common infectious agent. Despite conventional therapy consisting of proton pump inhibitor (PPI), amoxicillin (AMO) and clarithromycin (CLA), approximately half of the patients remain infected. We compared the PPI-based triple therapy with quadruple treatment (BPMT) including bismuth citrate (BS), PPI, metronidazole (MET) and tetracycline (TET).